News & Updates
Filter by Specialty:
12-year HK data: Clozapine reduces suicide mortality risk in patients with schizophrenia
Continuous use of clozapine reduces the risk of suicide mortality in patients with schizophrenia, according to a 12-year population-based cohort study in Hong Kong.
12-year HK data: Clozapine reduces suicide mortality risk in patients with schizophrenia
01 Aug 2025
Meta-analysis points to exercise as effective treatment strategy for insomnia
Exercise interventions such as yoga, Tai Chi, and walking or jogging help improve sleep outcomes for people with insomnia, according to the results of a meta-analysis.
Meta-analysis points to exercise as effective treatment strategy for insomnia
25 Jul 2025
Rice bran extract eases depressive symptoms in adults
Daily intake of rice bran extract supplements (RBS) appears effective in reducing depressive symptoms in adults with mild-to-moderate symptom severity, reports a study, noting improvements reaching clinically relevant thresholds.
Rice bran extract eases depressive symptoms in adults
21 Jul 2025
Pandemic fuels burden of non-COVID diseases
Disease burden has significantly increased because of the COVID-19 pandemic, particularly mental health disorders, malaria in young children in the African region, and stroke and ischaemic heart disease in older adults, reports a study.
Pandemic fuels burden of non-COVID diseases
19 Jul 2025
Esketamine monotherapy shows robust, rapid efficacy as treatment for TRD
Intranasal esketamine, administered at two fixed doses as monotherapy for treatment-resistant depression (TRD), has demonstrated robust and rapid efficacy in a phase IV double-blind, placebo-controlled randomized trial.